| ANTX | | AN2 Therapeutics, Inc. | Ra Capital Management, L.P. | 10% Owner | Jun 13, 2022 | Buy | $7.90 | 20,000 | 158,000 | 3,686,663 | Jun 15, 2022, 04:25 PM |
| ANTX | | AN2 Therapeutics, Inc. | Ra Capital Management, L.P. | 10% Owner | Jun 14, 2022 | Buy | $7.97 | 61,424 | 489,402 | 3,748,087 | Jun 15, 2022, 04:25 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | May 26, 2022 | Sale | $0.36 | 1,005,686 | 365,667 | 7,039,613 | May 26, 2022, 05:09 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | May 25, 2022 | Sale | $0.42 | 1,434,509 | 602,494 | 8,045,299 | May 25, 2022, 05:17 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | May 23, 2022 | Sale | $0.65 | 1,250,000 | 812,500 | 9,624,613 | May 25, 2022, 05:17 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | May 24, 2022 | Sale | $0.51 | 144,805 | 73,851 | 9,479,808 | May 25, 2022, 05:17 PM |
| PEPG | | PepGen Inc. | Ra Capital Management, L.P. | Director | May 10, 2022 | Conversion | - | 4,902,752 | - | 3,642,229 | May 12, 2022, 07:06 PM |
| PEPG | | PepGen Inc. | Ra Capital Management, L.P. | Director | May 10, 2022 | Buy | $12.00 | 3,229,200 | 38,750,400 | 6,621,680 | May 12, 2022, 07:06 PM |
| NKTX | | Nkarta, Inc. | Ra Capital Management, L.P. | Director | Apr 26, 2022 | Buy | $15.00 | 2,200,000 | 33,000,000 | 7,805,129 | Apr 28, 2022, 04:32 PM |
| ANTX | | AN2 Therapeutics, Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 29, 2022 | Buy | $15.00 | 1,666,666 | 24,999,990 | 3,251,051 | Mar 31, 2022, 04:31 PM |
| ANTX | | AN2 Therapeutics, Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 29, 2022 | Conversion | - | 1,999,997 | - | 1,699,998 | Mar 31, 2022, 04:31 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 14, 2022 | Buy | $12.35 | 342,143 | 4,223,926 | 13,139,327 | Mar 16, 2022, 05:10 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 15, 2022 | Buy | $12.27 | 241,727 | 2,964,999 | 13,381,054 | Mar 16, 2022, 05:10 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 10, 2022 | Buy | $12.95 | 256,992 | 3,327,584 | 12,459,692 | Mar 11, 2022, 05:27 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 11, 2022 | Buy | $12.77 | 337,492 | 4,309,334 | 12,797,184 | Mar 11, 2022, 05:27 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 09, 2022 | Buy | $12.99 | 40,154 | 521,753 | 12,202,700 | Mar 11, 2022, 05:27 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 04, 2022 | Buy | $12.99 | 63,662 | 827,230 | 11,578,944 | Mar 08, 2022, 04:59 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 07, 2022 | Buy | $12.61 | 337,901 | 4,260,965 | 11,916,845 | Mar 08, 2022, 04:59 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 08, 2022 | Buy | $12.86 | 245,701 | 3,160,059 | 12,162,546 | Mar 08, 2022, 04:59 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 02, 2022 | Buy | $12.89 | 138,255 | 1,782,218 | 11,515,282 | Mar 02, 2022, 05:29 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 28, 2022 | Buy | $12.97 | 8,746 | 113,430 | 11,082,163 | Mar 02, 2022, 05:29 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Mar 01, 2022 | Buy | $12.98 | 294,864 | 3,826,303 | 11,377,027 | Mar 02, 2022, 05:29 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 23, 2022 | Buy | $13.41 | 214,922 | 2,883,114 | 10,867,959 | Feb 25, 2022, 05:43 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 24, 2022 | Buy | $13.03 | 186,467 | 2,429,852 | 11,054,426 | Feb 25, 2022, 05:43 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 25, 2022 | Buy | $12.99 | 18,991 | 246,699 | 11,073,417 | Feb 25, 2022, 05:43 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 22, 2022 | Buy | $13.46 | 214,922 | 2,892,055 | 10,653,037 | Feb 22, 2022, 05:22 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 17, 2022 | Buy | $14.78 | 166,229 | 2,457,264 | 10,271,886 | Feb 22, 2022, 05:22 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 18, 2022 | Buy | $14.12 | 166,229 | 2,346,389 | 10,438,115 | Feb 22, 2022, 05:22 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 14, 2022 | Buy | $14.72 | 166,229 | 2,446,924 | 9,773,257 | Feb 16, 2022, 07:39 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 15, 2022 | Buy | $14.99 | 166,200 | 2,490,524 | 9,939,457 | Feb 16, 2022, 07:39 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Feb 16, 2022 | Buy | $14.98 | 166,200 | 2,489,377 | 10,105,657 | Feb 16, 2022, 07:39 PM |
| TYRA | | Tyra Biosciences, Inc. | Ra Capital Management, L.P. | Director | Sep 17, 2021 | Conversion | - | 5,986,454 | - | 4,047,120 | Sep 17, 2021, 04:34 PM |
| TYRA | | Tyra Biosciences, Inc. | Ra Capital Management, L.P. | Director | Sep 17, 2021 | Buy | $16.00 | 1,250,000 | 20,000,000 | 5,297,120 | Sep 17, 2021, 04:34 PM |
| ELYM | | Eliem Therapeutics, Inc. | Ra Capital Management, L.P. | Director | Aug 12, 2021 | Conversion | - | 6,867,517 | - | 7,594,804 | Aug 16, 2021, 04:47 PM |
| ELYM | | Eliem Therapeutics, Inc. | Ra Capital Management, L.P. | Director | Aug 12, 2021 | Buy | $12.50 | 3,200,000 | 40,000,000 | 10,599,586 | Aug 16, 2021, 04:47 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Jul 27, 2021 | Buy | $17.00 | 2,950,000 | 50,150,000 | 7,913,537 | Jul 29, 2021, 04:30 PM |
| CTKB | | Cytek Biosciences, Inc. | Ra Capital Management, L.P. | Director | Jul 27, 2021 | Conversion | - | 6,657,028 | - | 5,150,751 | Jul 29, 2021, 04:30 PM |
| ABOS | | Acumen Pharmaceuticals, Inc. | Ra Capital Management, L.P. | Director | Jul 06, 2021 | Conversion | - | 7,895,773 | - | 6,122,557 | Jul 08, 2021, 04:32 PM |
| ABOS | | Acumen Pharmaceuticals, Inc. | Ra Capital Management, L.P. | Director | Jul 06, 2021 | Buy | $16.00 | 1,875,000 | 30,000,000 | 7,881,889 | Jul 08, 2021, 04:32 PM |
| AVTE | | Aerovate Therapeutics, Inc. | Ra Capital Management, L.P. | Director | Jul 02, 2021 | Conversion | - | 5,236,801 | - | 4,179,854 | Jul 06, 2021, 05:03 PM |
| AVTE | | Aerovate Therapeutics, Inc. | Ra Capital Management, L.P. | Director | Jul 02, 2021 | Buy | $14.00 | 2,785,714 | 38,999,996 | 6,965,568 | Jul 06, 2021, 05:03 PM |
| ETNB | | 89bio, Inc. | Ra Capital Management, L.P. | Director | Jun 02, 2021 | Buy | $18.77 | 22,138 | 415,530 | 4,965,769 | Jun 04, 2021, 04:31 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Ra Capital Management, L.P. | Director | May 04, 2021 | Conversion | - | 2,253,583 | - | 1,915,546 | May 06, 2021, 04:31 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Ra Capital Management, L.P. | Director | May 04, 2021 | Buy | $16.00 | 1,715,000 | 27,440,000 | 3,524,758 | May 06, 2021, 04:31 PM |
| SLDB | | Solid Biosciences Inc. | Ra Capital Management, L.P. | Director | Mar 19, 2021 | Buy | $5.75 | 2,206,685 | 12,688,439 | 10,916,567 | Mar 23, 2021, 04:30 PM |
| PHAT | | Phathom Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 11, 2021 | Sale | $43.75 | 710,000 | 31,062,500 | 3,115,008 | Mar 15, 2021, 04:36 PM |
| VOR | | Vor Biopharma Inc. | Ra Capital Management, L.P. | Director | Feb 09, 2021 | Conversion | - | 7,143,025 | - | 5,448,669 | Feb 09, 2021, 06:25 PM |
| VOR | | Vor Biopharma Inc. | Ra Capital Management, L.P. | Director | Feb 09, 2021 | Buy | $18.00 | 2,979,566 | 53,632,188 | 8,297,265 | Feb 09, 2021, 06:25 PM |
| ITRM | | Iterum Therapeutics plc | Ra Capital Management, L.P. | 10% Owner | Feb 04, 2021 | Conversion | - | 11,651,597 | - | 11,651,597 | Feb 08, 2021, 05:22 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | Former 10% Owner | Dec 02, 2020 | Sale | $32.39 | 30,939 | 1,002,261 | 4,580,524 | Dec 04, 2020, 04:30 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | Former 10% Owner | Dec 03, 2020 | Sale | $29.03 | 207,604 | 6,027,391 | 4,557,882 | Dec 04, 2020, 04:30 PM |
| PCVX | | Vaxcyte, Inc. | Ra Capital Management, L.P. | 10% Owner | Oct 08, 2020 | Sale | $50.69 | 167,661 | 8,498,066 | 5,001,593 | Oct 09, 2020, 04:22 PM |
| PCVX | | Vaxcyte, Inc. | Ra Capital Management, L.P. | 10% Owner | Oct 07, 2020 | Sale | $50.95 | 98,597 | 5,023,527 | 5,169,254 | Oct 09, 2020, 04:22 PM |
| PCVX | | Vaxcyte, Inc. | Ra Capital Management, L.P. | 10% Owner | Sep 29, 2020 | Sale | $52.08 | 80,707 | 4,202,986 | 5,408,474 | Oct 01, 2020, 05:25 PM |
| PCVX | | Vaxcyte, Inc. | Ra Capital Management, L.P. | 10% Owner | Sep 30, 2020 | Sale | $50.27 | 124,656 | 6,265,871 | 5,283,818 | Oct 01, 2020, 05:25 PM |
| PCVX | | Vaxcyte, Inc. | Ra Capital Management, L.P. | 10% Owner | Oct 01, 2020 | Sale | $48.64 | 15,967 | 776,705 | 5,267,851 | Oct 01, 2020, 05:25 PM |
| PMVP | | PMV Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | Sep 29, 2020 | Buy | $18.00 | 950,000 | 17,100,000 | 1,710,265 | Sep 29, 2020, 04:30 PM |
| PMVP | | PMV Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | Sep 29, 2020 | Conversion | - | 760,265 | - | 760,265 | Sep 29, 2020, 04:30 PM |
| DYN | | Dyne Therapeutics, Inc. | Ra Capital Management, L.P. | 10% Owner | Sep 21, 2020 | Conversion | - | 2,145,045 | - | 2,145,045 | Sep 23, 2020, 06:55 PM |
| DYN | | Dyne Therapeutics, Inc. | Ra Capital Management, L.P. | 10% Owner | Sep 21, 2020 | Buy | $19.00 | 660,000 | 12,540,000 | 2,805,045 | Sep 23, 2020, 06:55 PM |
| ETNB | | 89bio, Inc. | Ra Capital Management, L.P. | Director | Sep 17, 2020 | Buy | $28.00 | 1,300,000 | 36,400,000 | 4,736,214 | Sep 21, 2020, 04:30 PM |
| TGTX | | TG THERAPEUTICS, INC. | Ra Capital Management, L.P. | 10% Owner | Sep 09, 2020 | Sale | $25.81 | 158,589 | 4,092,738 | 12,629,868 | Sep 11, 2020, 04:31 PM |
| NKTX | | Nkarta, Inc. | Ra Capital Management, L.P. | 10% Owner | Jul 14, 2020 | Conversion | - | 2,271,796 | - | 2,271,796 | Jul 16, 2020, 04:30 PM |
| NKTX | | Nkarta, Inc. | Ra Capital Management, L.P. | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 3,333,333 | 59,999,994 | 5,605,129 | Jul 16, 2020, 04:30 PM |
| ETNB | | 89bio, Inc. | Ra Capital Management, L.P. | Director | Jul 08, 2020 | Buy | $27.50 | 275,000 | 7,562,500 | 3,436,214 | Jul 10, 2020, 04:32 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | 10% Owner | Jun 30, 2020 | Sale | $22.15 | 61,901 | 1,371,237 | 5,210,088 | Jul 02, 2020, 04:46 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | 10% Owner | Jul 01, 2020 | Sale | $21.87 | 25,527 | 558,311 | 5,184,561 | Jul 02, 2020, 04:46 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | 10% Owner | Jul 02, 2020 | Sale | $22.04 | 44,153 | 972,969 | 5,140,408 | Jul 02, 2020, 04:46 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | 10% Owner | Jun 25, 2020 | Sale | $25.05 | 11,568 | 289,768 | 5,410,744 | Jun 29, 2020, 06:31 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | 10% Owner | Jun 26, 2020 | Sale | $23.31 | 86,706 | 2,020,848 | 5,324,038 | Jun 29, 2020, 06:31 PM |
| RYTM | | RHYTHM PHARMACEUTICALS, INC. | Ra Capital Management, L.P. | 10% Owner | Jun 29, 2020 | Sale | $22.19 | 52,049 | 1,154,999 | 5,271,989 | Jun 29, 2020, 06:31 PM |
| VSTM | | Verastem, Inc. | Ra Capital Management, L.P. | 10% Owner | Jun 25, 2020 | Sale | $1.91 | 1,161,300 | 2,219,941 | 16,142,051 | Jun 29, 2020, 06:29 PM |
| VSTM | | Verastem, Inc. | Ra Capital Management, L.P. | 10% Owner | Apr 27, 2020 | Sale | $2.31 | 1,301,300 | 3,002,099 | 17,303,351 | Apr 29, 2020, 04:30 PM |
| PHAT | | Phathom Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | Apr 01, 2020 | Buy | $24.86 | 117,600 | 2,923,642 | 3,825,008 | Apr 03, 2020, 04:30 PM |
| PHAT | | Phathom Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 27, 2020 | Buy | $24.60 | 30,000 | 738,000 | 3,676,808 | Mar 31, 2020, 05:02 PM |
| PHAT | | Phathom Pharmaceuticals, Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 31, 2020 | Buy | $24.55 | 30,600 | 751,264 | 3,707,408 | Mar 31, 2020, 05:02 PM |
| IMRA | | IMARA Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 16, 2020 | Conversion | - | 829,348 | - | 829,348 | Mar 17, 2020, 04:31 PM |
| IMRA | | IMARA Inc. | Ra Capital Management, L.P. | 10% Owner | Mar 16, 2020 | Buy | $16.00 | 625,000 | 10,000,000 | 1,454,348 | Mar 17, 2020, 04:31 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, L.P. | Director | Mar 13, 2020 | Buy | $7.89 | 6,337,135 | 49,999,994 | 10,874,613 | Mar 13, 2020, 06:45 PM |
| ETNB | | 89bio, Inc. | Ra Capital Management, L.P. | Director | Nov 11, 2019 | Buy | $16.00 | 1,500,000 | 24,000,000 | 1,500,000 | Nov 13, 2019, 07:06 PM |
| ETNB | | 89bio, Inc. | Ra Capital Management, L.P. | Director | Nov 13, 2019 | Conversion | - | 1,661,214 | - | 3,161,214 | Nov 13, 2019, 07:06 PM |
| WVE | | Wave Life Sciences Ltd. | Ra Capital Management, LLC | Director | Jan 24, 2019 | Buy | $38.00 | 263,158 | 10,000,004 | 7,775,207 | Jan 28, 2019, 04:33 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, LLC | Director | Oct 03, 2018 | Buy | $8.25 | 2,424,242 | 19,999,997 | 4,537,478 | Oct 05, 2018, 04:33 PM |
| ARVN | | ARVINAS INC. | Ra Capital Management, LLC | Former 10% Owner | Oct 01, 2018 | Buy | $16.00 | 1,000,000 | 16,000,000 | 3,138,412 | Oct 03, 2018, 04:36 PM |
| ARVN | | ARVINAS INC. | Ra Capital Management, LLC | Former 10% Owner | Oct 01, 2018 | Conversion | - | 2,138,412 | - | 2,138,412 | Oct 03, 2018, 04:36 PM |
| WVE | | Wave Life Sciences Ltd. | Ra Capital Management, LLC | Director | Nov 13, 2017 | Buy | $23.30 | 400,000 | 9,320,000 | 7,488,651 | Nov 15, 2017, 04:35 PM |
| WVE | | Wave Life Sciences Ltd. | Ra Capital Management, LLC | Director | Nov 14, 2017 | Buy | $24.00 | 23,398 | 561,550 | 7,512,049 | Nov 15, 2017, 04:35 PM |
| KALV | | KalVista Pharmaceuticals, Inc. | Ra Capital Management, LLC | Director | Oct 12, 2017 | Buy | $8.50 | 850,000 | 7,225,000 | 1,441,070 | Oct 16, 2017, 04:32 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, LLC | Director | Jul 25, 2017 | Buy | $15.00 | 533,333 | 7,999,995 | 2,113,236 | Jul 26, 2017, 04:44 PM |
| KALA | | Kala Pharmaceuticals, Inc. | Ra Capital Management, LLC | Director | Jul 25, 2017 | Conversion | - | 1,579,903 | - | 1,579,903 | Jul 26, 2017, 04:44 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Sep 15, 2016 | Sale | $24.04 | 351,950 | 8,459,290 | 2,607,719 | Sep 19, 2016, 05:15 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Sep 16, 2016 | Sale | $24.51 | 173,600 | 4,254,212 | 2,125,769 | Sep 19, 2016, 05:15 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Feb 22, 2016 | Buy | $15.99 | 11,318 | 180,958 | 2,599,311 | Feb 24, 2016, 04:56 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Feb 23, 2016 | Buy | $17.62 | 28,408 | 500,512 | 2,627,719 | Feb 24, 2016, 04:56 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Jan 15, 2016 | Buy | $19.86 | 1,800 | 35,743 | 2,581,990 | Jan 20, 2016, 04:51 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Jan 19, 2016 | Buy | $19.88 | 4,200 | 83,480 | 2,586,190 | Jan 20, 2016, 04:51 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Jan 20, 2016 | Buy | $19.88 | 1,803 | 35,849 | 2,587,993 | Jan 20, 2016, 04:51 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Jan 12, 2016 | Buy | $19.12 | 5,941 | 113,585 | 2,574,647 | Jan 13, 2016, 04:39 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Jan 13, 2016 | Buy | $19.97 | 5,543 | 110,674 | 2,580,190 | Jan 13, 2016, 04:39 PM |
| ACRS | | Aclaris Therapeutics, Inc. | Ra Capital Management, LLC | 10% Owner | Jan 11, 2016 | Buy | $17.93 | 4,153 | 74,479 | 2,568,706 | Jan 13, 2016, 04:39 PM |
